Delivery Order SPE2DR25D6028-SPE2DR26FASUL
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,541.90 by the Defense Logistics Agency (DLA) on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitive award, which carries no set-aside designation, is for the supply of Vemlidy 25 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a delivery order, indicating it derives from a larger indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,202.38 by the Defense Logistics Agency (DLA) on December 10, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 11, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on October 31, 2025, for Vemlidy 25 mg tablets in a package quantity of 30 units. This competitive, non-set-aside contract carries a ceiling value of $1,198.50 and is structured as a firm fixed-price delivery order, with an ultimate completion date of November 3, 2025. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $23,466.99. The contract is a non-set-aside award funded by the Defense Logistics Agency's Medical Supply Chain, with a completion date of September 25, 2025. This delivery order represents a specific fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,299.76 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,245.84 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,265.45 on October 15, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This non-competitive delivery order is a firm fixed price contract with a completion date of October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $7,213.88. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,018.04 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit packaging) under a firm fixed-price contract valued at $25,330.47. The delivery order, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a non-set-aside award issued through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASULDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,822.50 by the Defense Logistics Agency on December 16, 2025, for the supply of Vemlidy 25mg tablets (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 17, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The underlying IDC demonstrates the company's established capability to meet federal procurement requirements and deliver critical medical commodities across multiple therapeutic domains to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 12/15/25 |